Delaying the GABA Shift Indirectly Affects Membrane Properties in the Developing Hippocampus.
Carlijn Peerboom1, Sam de Kater1, Nikki Jonker1
1Cell Biology, Neurobiology and Biophysics, Biology Department, Utrecht University, Utrecht, 3584 CH, The Netherlands.
Summary
A delayed shift in GABA signaling during early brain development does not directly impact synapse formation but indirectly alters neuronal excitability. This finding is crucial for understanding neurodevelopmental disorders.
Area of Science:
- Neuroscience
- Developmental Biology
Background:
- During early postnatal development, GABAergic signaling shifts from depolarizing to hyperpolarizing in rodents.
- This developmental shift is often delayed in neurodevelopmental disorders, but its precise impact is unclear.
Purpose of the Study:
- To investigate the direct and indirect effects of a delayed postnatal GABA shift on hippocampal network development.
- To determine if delayed GABAergic signaling influences synapse formation and neuronal excitability.
Main Methods:
- Organotypic hippocampal slice cultures from young mice were treated with VU0463271, a KCC2 inhibitor, to delay the GABA shift.
- Electrophysiological recordings and synaptic property analyses were performed at different developmental time points.
Main Results:
- VU0463271 treatment successfully delayed the shift to hyperpolarizing GABA responses.
- No immediate effects on excitatory or inhibitory synapse development were observed.
- Delayed GABA shift led to increased inhibitory postsynaptic current frequency and altered neuronal excitability in specific cell types by later developmental stages.
Conclusions:
- Depolarizing GABA signaling does not promote synapse formation after the first postnatal week.
- Postnatal intracellular chloride levels indirectly influence neuronal membrane properties in a cell-specific manner.
- Altered cellular excitability may be a key factor in neurodevelopmental disorders associated with delayed GABA shifts.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K


